Orca Biosystems, Inc.
Clinical trials sponsored by Orca Biosystems, Inc., explained in plain language.
-
Scientists test 'Engineered' transplant to fight blood cancers with fewer side effects
Disease control Recruiting nowThis early-stage trial is testing the safety of a modified donor stem cell transplant, called Orca-Q, for people with certain blood cancers like leukemia. The goal is to see if this engineered transplant can help patients recover their blood counts while reducing serious complica…
Phase: PHASE1 • Sponsor: Orca Biosystems, Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New cell therapy aims to tame transplant dangers for frail blood cancer patients
Disease control Recruiting nowThis study is testing a new cell therapy called Orca-T for adults with acute myeloid leukemia or myelodysplastic syndrome who need a stem cell transplant but are too frail for the strongest chemotherapy. The therapy uses specially prepared donor cells to help rebuild the patient'…
Phase: PHASE2 • Sponsor: Orca Biosystems, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC